UBS Group Balance Sheet Health

Financial Health criteria checks 4/6

UBS Group has total assets of $1,717.2B and total equity of $86.6B. Total deposits are $792.0B, and total loans are $655.3B earning a Net Interest Margin of 0.6%. It has insufficient allowance for bad loans, which are currently at 0.9% of total loans. Cash and short-term investments are $591.2B.

Key information

19.8x

Asset to equity ratio

0.6%

Net interest margin

Total deposits

US$792.03b

Loan to deposit ratio

Appropriate

Bad loans

0.9%

Allowance for bad loans

Low

Current ratio

Low

Cash & equivalents

US$591.22b

Recent financial health updates

No updates

Recent updates

UBS: To Play It Safe

Apr 20

Momentum Has Shown That Despite The Risks, UBS Is A Worthy Investment (Rating Upgrade)

Jan 25

UBS: Mixed Q3 Earnings, Hold

Nov 10

UBS Q2 Earnings: Lot More To Do

Aug 31

UBS: The Thrill Of Risk And Potential Reward, But Wait For Earnings

Jul 17

UBS Group: Resume With An Equal-Weight Valuation

Jul 06

UBS Group AG: Undervalued And Poised For Post-Takeover Upside

May 31

UBS plans to apply for mutual-fund license in China: WSJ

Feb 23

UBS GAAP EPS of $0.50, revenue of $8.03B beats by $60M

Jan 31

UBS plans to bolster M&A dealmaker ranks as Wall Street firms pare down - report

Jan 20

UBS: Holding Up Relatively Well In Spite Of Macroeconomic Threats

Dec 16

Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet


Financial Institutions Analysis

Asset Level: UBS's Assets to Equity ratio (19.8x) is moderate.

Allowance for Bad Loans: UBS has a low allowance for bad loans (40%).

Low Risk Liabilities: 51% of UBS's liabilities are made up of primarily higher risk sources of funding.

Loan Level: UBS has an appropriate level of Loans to Assets ratio (38%).

Low Risk Deposits: UBS's Loans to Deposits ratio (83%) is appropriate.

Level of Bad Loans: UBS has an appropriate level of bad loans (0.9%).


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.